AaronLisbergMD

PubMed

• Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
  Toshio Shimizu, Noboru Yamamoto, Takahiro Kogawa, Francesca Pisetzky, Priyanka Basak, Cindy Lau, Rebecca S Heist, Jacob Sands, Aditya Bardia, Aaron Lisberg, Ian Krop, ...> ;Cancer Treatment Reviews. 2024 Apr 1
• 1 citations
  CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
  Shabihkhani, M., Shabihkhani, M., Ramin Salehi-Rad, Raymond J Lim, Yushen Du, Linh M Tran, Rui Li, Stephanie L Ong, Zi Ling Huang, Camelia Dumitras, Tianhao Zhang, Sta...> ;Journal for Immunotherapy of Cancer. 2023 Sep 1
• 1 citations
  Letter to Editor. Re "de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer," Semaglutide a Potential Treatment ...
  Alexandria T M Lee, Sai-Hong Ignatius Ou, Aaron Lisberg> ;Journal of Thoracic Oncology. 2023 Sep 1
• 1 citations
  Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.
  Drew Moghanaki, Aaron Lisberg, Scott Oh, Jay Moon Lee> ;Journal of Thoracic Oncology. 2023 Sep 1
• 2 citations
  Consent document translation expense hinders inclusive clinical trial enrolment.
  Maria A Velez, Beth A Glenn, Maria Garcia-Jimenez, Amy L Cummings, Aaron Lisberg, Andrea Nañez, Yazeed Radwan, Jackson P Lind-Lebuffe, Paige M Brodrick, Debory Y Li, M...> ;Nature. 2023 Aug 1
• 2 citations
  Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
  Mathilde Beaufils, Vincent Amodru, Manuel Tejeda, Jean Marie Boher, Christophe Zemmour, Brice Chanez, Anne Sophie Chrétien, Laurent Gorvel, Gwenaelle Gravis, Damien Br...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
• An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors.
  Brandon Nadres, Milica Momcilovic, David B Shackelford, Aaron Lisberg> ;Journal of Thoracic Oncology. 2023 Jul 1
• 5 citations
  First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-S...
  Toshio Shimizu, Jacob Sands, Kiyotaka Yoh, Alexander Spira, Edward B Garon, Satoru Kitazono, Melissa L Johnson, Funda Meric-Bernstam, Anthony W Tolcher, Noboru Yamamot...> ;Journal of Clinical Oncology. 2023 Oct 10
• 1 citations
  Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-S...
  Trudy C Wu, Annalise Stube, Carol Felix, Denise Oseguera, Tahmineh Romero, Jonathan Goldman, Edward B Garon, Jay M Lee, John Glaspy, Aaron E Lisberg, Chad G Rusthoven,...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Sep 1
• 17 citations
  Spatial mapping of mitochondrial networks and bioenergetics in lung cancer.
  Mingqi Han, Eric A Bushong, Mayuko Segawa, Alexandre Tiard, Alex Wong, Morgan R Brady, Milica Momcilovic, Dane M Wolf, Ralph Zhang, Anton Petcherski, Matthew Madany, S...> ;Nature. 2023 Mar 1
• 1 citations
  Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.
  Clayton P Smith, Michael Xiang, Stephanie M Yoon, Alan Lee, Dan Ruan, Jonathan W Goldman, Amy L Cummings, Aaron Lisberg, Edward B Garon, Drew Moghanaki> ;JTO Clinical and Research Reports. 2023 Mar 1
• What is the current role of immunotherapy in EGFR mutant advanced NSCLC?
  Maria A Velez, Hsin Hsiang Clarence Tsai, David B Shackelford, Edward B Garon, Aaron Lisberg> ;Lung Cancer. 2022 Apr 1
• 2 citations
  Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC.
  Puja Shahrouki, Jay M. Lee, Jonathan Barclay, Sarah N Khan, Scott Genshaft, Fereidoun Abtin, Steven M. Dubinett, Aaron Lisberg, Sherven Sharma, Edward B. Garon, Robert...> ;JTO Clinical and Research Reports. 2021 Oct 14
• 6 citations
  Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.
  Nanruoyi Zhou, Maria A. Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene M. Fares, Amy L. Cummings, Jackson P. Lind-Lebuffe, Wisdom O. Akingbemi, Debory Y. Li, Paig...> ;Lung Cancer. 2021 Aug 30
• Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: En...
  Scott Genshaft, Robert D. Suh, Fereidoun Abtin, Mark O. Baerlocher, Albert J. Chang, Sean R. Dariushnia, A. Michael Devane, Salomao Faintuch, Elizabeth A. Himes, Aaron...> ;Journal of Vascular and Interventional Radiology. 2021 Aug 1
• 12 citations
  Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation of Non-Small Cell Lung Cancer and Metastatic Disease to the Lungs.
  Scott Genshaft, Robert D. Suh, Fereidoun Abtin, Mark O. Baerlocher, Sean R. Dariushnia, A. Michael Devane, Elizabeth A. Himes, Aaron Lisberg, Siddharth A. Padia, Sheen...> ;Journal of Vascular and Interventional Radiology. 2021 May 14
• 17 citations
  Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44
  Amy L. Cummings, Jaklin Gukasyan, Henry Lu, Tristan Grogan, Gemalene Sunga, Charlene M. Fares, Nicholas Hornstein, Jesse M. Zaretsky, James M. Carroll, Benjamin Bachra...> ;Nature Cancer. 2020 Nov 16
• 3 citations
  Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy.
  Nanruoyi Zhou, Maria Velez, Dwight H. Owen, Aaron Lisberg> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
• 226 citations
  EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
  Katherine Hastings, Helena A. Yu, Wei Wei, Francisco Sanchez-Vega, Michelle DeVeaux, Jungmin Choi, Hira Rizvi, Aaron Lisberg, A. Truini, Christine A. Lydon, Zongzhi Li...> ;Annals of Oncology. 2019 Aug 1
• 49 citations
  Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer
  Siwen Hu-Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Tristan Grogan, Hira Rizvi, Daniel K. Wells, James M. Carroll, Amy L. Cummings, John Madrigal, Benjamin P Jones, ...> ;Clinical Cancer Research. 2019 May 21
• 2 citations
  Lack of clearly defined role for anti-programmed death-(ligand) 1 therapy in epidermal growth factor receptor mutated non-small cell lung cancer.
  Aaron Lisberg, Edward B. Garon> ;Translational Lung Cancer Research. 2019 Apr 1
• 8 citations
  Does Platinum-Based Chemotherapy Still Have a Role in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer?
  Aaron Lisberg, Edward B. Garon> ;Journal of Clinical Oncology. 2019 Jan 24
• 5 citations
  The Italian Nivolumab Expanded Access Program Confirms the Limitations of Single-Agent PD-1 Inhibition in EGFR-Mutant and Never-Smoking Patients with NSCLC.
  Aaron Lisberg, Edward B. Garon> ;Journal of Thoracic Oncology. 2018 Aug 1
• 66 citations
  Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center.
  Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman, Brian R. Wolf, James M. Carroll, Ariana R. Hardy, Karolyn K. Morris, Paulina J Linares, Carlos R. Adame, Marshall...> ;Cancer Immunology Research. 2018 Jan 30
• High-profile studies frequently and repetitively present data on the same patients, particularly in immunotherapy studies
  Tim Ellis-Caleo, Aaron Lisberg, D. Andrew Tucker, Edward B. Garon> ;Journal of Thoracic Disease. 2018 Jan 29
• Join now to see all